← Browse by Condition
Medical Condition
pleomorphic rhabdomyosarcoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT07169344 Phase 2
Recruiting
Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma
Enrollment
110 pts
Location
Norway
Sponsor
Oslo University Hospital
NCT06277154 Phase 2
Recruiting
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
Enrollment
148 pts
Location
China
Sponsor
HRYZ Biotech Co.